Assignee
AVIGEN INC
US·35 granted patents·12 pending applications·2,657 citations·filing 1995–2009
Top patents by PatentIndex Score
47 records- 0198US6001650AHigh-efficiency wild-type-free AAV helper functionsAVIGEN INC·Filed 1998·Granted Dec 14, 1999·259 cites·25 claims
- 0297US6610290B2Adeno associated virus vectors for the treatment of a cardiomyopathyAVIGEN INC·Filed 2001·Granted Aug 26, 2003·75 cites·8 claims
- 0397US5962313AAdeno-associated virus vectors comprising a gene encoding a lyosomal enzymeAVIGEN INC·Filed 1997·Granted Oct 5, 1999·203 cites·6 claims
- 0497US5858351AMethods for delivering DNA to muscle cells using recombinant adeno-associated virus vectorsAVIGEN INC·Filed 1996·Granted Jan 12, 1999·223 cites·25 claims
- 0596US6593123B1Large-scale recombinant adeno-associated virus (rAAV) production and purificationAVIGEN INC·Filed 2000·Granted Jul 15, 2003·110 cites·21 claims
- 0696US6531456B1Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectorsAVIGEN INC·Filed 2000·Granted Mar 11, 2003·75 cites·11 claims
- 0796US5952221AAdeno-associated virus vectors comprising a first and second nucleic acid sequenceAVIGEN INC·Filed 1997·Granted Sep 14, 1999·115 cites·6 claims
- 0895US6582692B1Recombinant adeno-associated virus virions for the treatment of lysosomal disordersAVIGEN INC·Filed 2000·Granted Jun 24, 2003·100 cites·8 claims
- 0995US6391858B2Methods for delivering DNA to the bloodstream using recombinant adeno-associated virus vectorsAVIGEN INC·Filed 2001·Granted May 21, 2002·38 cites·14 claims
- 1095US6309634B1Methods of treating Parkinson's disease using recombinant adeno-associated vector (rAAV)AVIGEN INC·Filed 1999·Granted Oct 30, 2001·177 cites·2 claims
- 1195US6200560B1Adeno-associated virus vectors for expression of factor VIII by target cellsAVIGEN INC·Filed 1999·Granted Mar 13, 2001·179 cites·25 claims
- 1295US5846528ATreating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequenceAVIGEN INC·Filed 1997·Granted Dec 8, 1998·96 cites·34 claims
- 1393US6376237B1High-efficiency wild-type-free AAV helper functionsAVIGEN INC·Filed 1999·Granted Apr 23, 2002·96 cites·17 claims
- 1493US6221349B1Adeno-associated vectors for expression of factor VIII by target cellsAVIGEN INC·Filed 1999·Granted Apr 24, 2001·136 cites·25 claims
- 1592US6710036B2Induction of immune response to antigens expressed by recombinant adeno-associated virusAVIGEN INC·Filed 2001·Granted Mar 23, 2004·63 cites·18 claims
- 1692US6335011B1Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions to treat lysosomal storage diseaseAVIGEN INC·Filed 1999·Granted Jan 1, 2002·79 cites·13 claims
- 1792US6004797AAdenovirus helper-free recombinant AAV Virion productionAVIGEN INC·Filed 1996·Granted Dec 21, 1999·95 cites·10 claims
- 1892US5843742AAdeno-associated derived vector systems for gene delivery and integration into target cellsAVIGEN INC·Filed 1995·Granted Dec 1, 1998·141 cites·40 claims
- 1991US6325998B1Methods of treating disease using recombinant adeno-associated virus virions administered to muscleAVIGEN INC·Filed 1998·Granted Dec 4, 2001·75 cites·24 claims
- 2091US6211163B1Methods for delivering DNA to the bloodstream using recombinant adeno-associated virus vectorsAVIGEN INC·Filed 1999·Granted Apr 3, 2001·78 cites·8 claims
- 2187US7585875B2Substituted pyrazolo[1,5-a]pyridine compounds and their methods of useAVIGEN INC·Filed 2007·Granted Sep 8, 2009·8 cites·9 claims
- 2287US6764845B2Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewithAVIGEN INC·Filed 2003·Granted Jul 20, 2004·20 cites·24 claims
- 2383US6027931AHigh-efficiency AA V helper functionsAVIGEN INC·Filed 1998·Granted Feb 22, 2000·45 cites·12 claims
- 2481US5945335AAdenovirus helper-free system for producing recombinant AAV virions lacking oncogenic sequencesAVIGEN INC·Filed 1998·Granted Aug 31, 1999·45 cites·21 claims
- 2580US7037713B2High-efficiency wild-type-free AAV helper functionsAVIGEN INC·Filed 2002·Granted May 2, 2006·4 cites·12 claims
- 2679US6365403B1High-efficiency AAV helper functionsAVIGEN INC·Filed 1999·Granted Apr 2, 2002·21 cites·13 claims
- 2778US6416992B1Compositions and methods for producing recombinant adeno-associated virusAVIGEN INC·Filed 1999·Granted Jul 9, 2002·42 cites·8 claims
- 2876US6218180B1Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectorsAVIGEN INC·Filed 1999·Granted Apr 17, 2001·25 cites·14 claims
- 2975US6897063B2Accessory functions for use in recombinant AAV virion productionAVIGEN INC·Filed 2002·Granted May 24, 2005·2 cites·18 claims
- 3066US7534806B2Method for treating neuropathic pain and associated syndromesAVIGEN INC·Filed 2005·Granted May 19, 2009·2 cites·15 claims
- 3165US2009253743A1Compositions of tolperisoneAVIGEN INC·Filed 2008·Application pending·0 cites
- 3264US2010035920A1SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USEAVIGEN INC·Filed 2009·Application pending·0 cites
- 3363US2004018627A1High-efficiency AAV helper functionsAVIGEN INC·Filed 2003·Application pending·0 cites
- 3463US2009098185A1Method for treating thrombotic disorders using sulfated polysaccharidesAVIGEN INC·Filed 2008·Application pending·0 cites
- 3561US2006094116A1High-efficiency wild-type-free AAV helper functionsAVIGEN INC·Filed 2005·Application pending·0 cites
- 3660US2006003453A1High-efficiency AAV helper functionsAVIGEN INC·Filed 2005·Application pending·0 cites
- 3758US2002115189A1High-efficiency AAV helper functionsAVIGEN INC·Filed 2001·Application pending·0 cites
- 3855US2009221629A1Method for antagonizing MIF activityAVIGEN INC·Filed 2009·Application pending·0 cites
- 3954US7622256B2Method for selecting compounds that modulate MIF-induced expression of ICAM-1 and/or VCAM-1AVIGEN INC·Filed 2007·Granted Nov 24, 2009·0 cites·1 claims
- 4054US2003044963A1Compositions and methods for producing recombinant adeno-associated virusAVIGEN INC·Filed 2002·Application pending·0 cites
- 4153US6759050B1Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewithAVIGEN INC·Filed 1999·Granted Jul 6, 2004·9 cites·15 claims
- 4253US2005153450A1Compositions and methods for producing recombinant adeno-associated virusAVIGEN INC·Filed 2005·Application pending·0 cites
- 4350US6207457B1Targeted nucleotide sequence delivery and integration systemAVIGEN INC·Filed 1995·Granted Mar 27, 2001·9 cites·17 claims
- 4449US2004087028A1Ecdysone-inducible adeno-associated virus expression vectorsAVIGEN INC·Filed 2003·Application pending·0 cites
- 4544US6242426B1Induction of immune response to antigens expressed by recombinant adeno-associated virusAVIGEN INC·Filed 1998·Granted Jun 5, 2001·10 cites·8 claims
- 4642US6482633B1Accessory functions for use in recombinant AAV virion productionAVIGEN INC·Filed 1999·Granted Nov 19, 2002·2 cites·17 claims
- 4727US2006073119A1Methods for treating neurodegenerative disordersAVIGEN INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AVIGEN INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →